Company
Tsumura & Co.
Headquarters: Tokyo, Japan
Employees: 3,830
CEO: Mr. Terukazu Kato
Market Cap
¥368.05 Billion
JPY as of Jan. 1, 2025
US$2.35 Billion
Tsumura & Co. Categories
Japan Healthcare Drug Manufacturers—Specialty & GenericJapan Healthcare Japan Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines, as well as Kampo powdered extracts; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | March 31, 2024 |
| Revenue TTM | ¥164.61 B |
| EBITDA | ¥34.58 B |
| Gross Profit TTM | ¥68.82 B |
| Profit Margin | 15.31% |
| Operating Margin | 23.14% |
| Quarterly Revenue Growth | 18.60% |
Stocks & Indices
Tsumura & Co. has the following listings and related stock indices.
Stock: JPX: 4540 wb_incandescent